Skip to main content
. 2017 Dec 13;7:17487. doi: 10.1038/s41598-017-17832-x

Figure 4.

Figure 4

Ex vivo HS-27 application retains contrast between tumor and non-tumor tissue. (a) Sample images of mouse tumor tissue treated ex vivo with 100 µM HS-27 or 100 µM inactivated HS-27 (HS-217) for one minute (b) Probability distribution functions (PDFs) of the HS-27 (n = 3) and HS-217 (n = 3) fluorescence values demonstrate significantly greater fluorescence in HS-27 treated samples than HS-217 treated samples. (c) Sample images of mouse tumor tissue and mouse skin tissue treated ex vivo with 100 µM HS-27 for one minute (d) PDFs of the HS-27 fluorescence values for both tumor (n = 3) and non-tumor (n = 3) are shown beneath the images. Fluorescence was significantly greater in tumor than non-tumor samples. (e) Sample images of tumor or non-tumor mouse tissue at 60-minutes after i.v. injection of 20 mg/kg HS-27. (f) PDFs of HS-27 fluorescence values for both tumor (n = 3) and non-tumor (n = 3) demonstrate significantly greater fluorescence in tumor than non-tumor samples. P-values were calculated using a Kolmogorov Smirnov test.